ePharmacy Market Research Report - Forecast till 2027

ePharmacy Market: Information by Drug Type (Prescription Drugs and Over the Counter (OTC) Drugs), Operating platform (App and Website), Business model (Marketplace, Pharmacy and Direct) and Region (Americas, Europe, Asia-Pacific and Rest of the World) - Forecast till 2027

ID: MRFR/HCIT/5152-HCR | February 2021 | Region: Global | 148 Pages         

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 16

1.1 OVERVIEW 16

1.1.1 MARKET SYNOPSIS 16

2 MARKET INTRODUCTION 17

2.1 SCOPE OF THE STUDY 17

2.2 RESEARCH OBJECTIVE 17

2.3 LIST OF ASSUMPTIONS 17

3 RESEARCH METHODOLOGY 19

3.1 OVERVIEW 19

3.2 DATA MINING 19

3.3 SECONDARY RESEARCH 20

3.4 PRIMARY RESEARCH 21

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 22

3.5 FORECASTING TECHNIQUES 22

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 23

3.6.1 BOTTOM-UP APPROACH 24

3.6.2 TOP-DOWN APPROACH 25

3.7 DATA TRIANGULATION 25

3.8 VALIDATION 25

4 MARKET DYNAMICS 26

4.1 OVERVIEW 26

4.2 DRIVERS 27

4.2.1 RISING ADOPTION RATE OF INTERNET AND HEALTHCARE APPS 27

4.2.2 RISING OCCURRENCE OF CHRONIC AND INFECTIOUS DISEASES 27

4.2.3 INCREASING GERIARTIC POPULATION 27

4.3 RESTRAINTS 28

4.3.1 COUNTERFEIT MEDICINES 28

4.4 OPPORTUNITIES 29

4.4.1 NEED FOR EPHARMACY SERVICES IN EMERGING ECONOMIES 29

5 MARKET FACTOR ANALYSIS 30

5.1 PORTER’S FIVE FORCES MODEL 30

5.1.1 THREAT OF NEW ENTRANTS 30

5.1.2 BARGAINING POWER OF SUPPLIERS 31

5.1.3 THREAT OF SUBSTITUTES 31

5.1.4 BARGAINING POWER OF BUYERS 31

5.1.5 INTENSITY OF RIVALRY 31

5.2 VALUE CHAIN ANALYSIS 32

5.2.1 INPUTS 32

5.2.2 SOFTWARE DEVELOPMENT PROCESSES 33

5.2.3 OUTPUT 33

5.2.4 MARKETING AND DISTRIBUTION 33

5.2.5 POST-SALES MONITORING 33

5.3 IMPACT OF COVID 19 ON EPHARMACY MARKET 34

5.3.3 IMPACT ON COST OF PRODUCT/SOFTWARE 35

5.3.1 IMPACT ON ADOPTION OF SOFTWARE 34

5.3.2 IMPACT ON ADOPTION OF CLOUD-BASED TECHNOLOGIES 35

6 GLOBAL EPHARMACY MARKET, BY DRUG TYPE 37

6.1 OVERVIEW 37

6.2 PRESCRIPTION DRUGS 39

6.3 OVER THE COUNTER (OTC) DRUGS 40

7 GLOBAL EPHARMACY MARKET, BY OPERATING PLATFORM 48

7.1 OVERVIEW 48

7.2 APP 50

7.3 WEBSITE 50

8 GLOBAL EPHARMACY MARKET, BY BUSINESS MODEL 51

8.1 OVERVIEW 52

8.2 MARKETPLACE 54

8.3 PHARMACY 55

8.4 DIRECT 56

9 GLOBAL EPHARMACY MARKET, BY REGION 58

9.1 OVERVIEW 58

9.2 AMERICAS 60

9.2.1 NORTH AMERICA 62

9.2.1.1 US 65

9.2.1.2 CANADA 67

9.2.2 LATIN AMERICA 69

9.3 EUROPE 71

9.3.1 WESTERN EUROPE 74

9.3.1.1 GERMANY 76

9.3.1.2 FRANCE 78

9.3.1.3 UK 79

9.3.1.4 ITALY 81

9.3.1.5 SPAIN 82

9.3.1.6 REST OF WESTERN EUROPE 84

9.3.2 EASTERN EUROPE 86

9.4 ASIA-PACIFIC 88

9.4.1 CHINA 91

9.4.2 JAPAN 92

9.4.3 INDIA 94

9.4.4 AUSTRALIA 95

9.4.5 SOUTH KOREA 97

9.4.6 REST OF ASIA-PACIFIC 98

9.5 MIDDLE EAST AND AFRICA 100

9.5.1 MIDDLE EAST 102

9.5.2 AFRICA 104

10 COMPETITIVE LANDSCAPE 106

10.1 OVERVIEW 106

10.2 COMPETITIVE BENCHMARKING 107

10.3 COMPETITOR DASHBOARD 108

10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL EPHARMACY MARKET 109

10.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL EPHARMACY MARKET 110

10.6 KEY DEVELOPMENT ANALYSIS 110

10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 111

10.7.1 ACQUISITION ACTIVITIES 111

10.7.2 NEW PRODUCTS/SERVICE LAUNCHES 112

10.7.3 COLLABORATIONS 113

10.7.4 PARTNERSHIPS 113

10.7.5 APPROVALS 113

11 COMPANY PROFILES 114

11.1 WALGREENS BOOTS ALLIANCE, INC.. 114

11.1.1 COMPANY OVERVIEW 114

11.1.2 FINANCIAL OVERVIEW 115

11.1.3 PRODUCTS/SERVICES OFFERED 116

11.1.4 KEY DEVELOPMENTS 117

11.1.5 SWOT ANALYSIS 118

11.1.6 KEY STRATEGIES 118

11.2 WAL-MART, INC. 119

11.2.1 COMPANY OVERVIEW 119

11.2.2 FINANCIAL OVERVIEW 119

11.2.3 PRODUCTS/SERVICES OFFERED 120

11.2.4 KEY DEVELOPMENTS 120

11.2.5 SWOT ANALYSIS 121

11.2.6 KEY STRATEGIES 121

11.3 CVS HEALTH... 122

11.3.1 COMPANY OVERVIEW 122

11.3.2 FINANCIAL OVERVIEW 123

11.3.3 PRODUCTS/SERVICES OFFERED 123

11.3.4 KEY DEVELOPMENTS 124

11.3.5 SWOT ANALYSIS 125

11.3.6 KEY STRATEGIES 125

11.4 DR. FOX PHARMACY 126

11.4.1 COMPANY OVERVIEW 126

11.4.2 FINANCIAL OVERVIEW 126

11.4.3 PRODUCTS/SERVICES OFFERED 127

11.4.4 KEY DEVELOPMENTS 127

11.4.5 SWOT ANALYSIS 128

11.4.6 KEY STRATEGIES 128

11.5 DOCMORRIS N.V. 129

11.5.1 COMPANY OVERVIEW 129

11.5.2 FINANCIAL OVERVIEW 129

11.5.3 PRODUCTS/SERVICES OFFERED 130

11.5.4 KEY DEVELOPMENTS 131

11.5.5 SWOT ANALYSIS 131

11.5.6 KEY STRATEGIES 131

11.6 ROWLANDS PHARMACY.. 132

11.6.1 COMPANY OVERVIEW 132

11.6.2 FINANCIAL OVERVIEW 132

11.6.3 PRODUCTS/SERVICES OFFERED 133

11.6.4 KEY DEVELOPMENTS 133

11.6.5 SWOT ANALYSIS 133

11.6.6 KEY STRATEGIES 134

11.7 OPTUMRX. 135

11.7.1 COMPANY OVERVIEW 135

11.7.2 FINANCIAL OVERVIEW 135

11.7.3 PRODUCTS/SERVICES OFFERED 136

11.7.4 KEY DEVELOPMENTS 136

11.7.5 SWOT ANALYSIS 137

11.7.6 KEY STRATEGIES 137

11.8 THE ONLINE DRUGSTORE. 138

11.8.1 COMPANY OVERVIEW 138

11.8.2 FINANCIAL OVERVIEW 138

11.8.3 PRODUCTS/SERVICES OFFERED 139

11.8.4 KEY DEVELOPMENTS 139

11.8.5 SWOT ANALYSIS 140

11.8.6 KEY STRATEGIES 140

11.9 WELL PHARMACY 141

11.9.1 COMPANY OVERVIEW 141

11.9.2 FINANCIAL OVERVIEW 141

11.9.3 KEY DEVELOPMENTS 142

11.9.4 SWOT ANALYSIS 143

11.9.5 KEY STRATEGIES 143

11.10 LLOYDSPHARMACY 144

11.10.1 COMPANY OVERVIEW 144

11.10.2 FINANCIAL OVERVIEW 145

11.10.3 PRODUCTS/SERVICES OFFERED 146

11.10.4 KEY DEVELOPMENTS 146

11.10.5 SWOT ANALYSIS 146

11.10.6 KEY STRATEGIES 147

12 APPENDIX 148

12.1 REFERENCES 148

12.2 RELATED REPORTS 148

 

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 17

TABLE 2 GLOBAL EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 39

TABLE 3 GLOBAL EPHARMACY MARKET, FOR PRESCRIPTION DRUGS, BY REGION, 2017–2027 (USD MILLION) 40

TABLE 4 GLOBAL EPHARMACY MARKET, FOR OVER THE COUNTER (OTC) DRUGS, BY REGION, 2017–2027 (USD MILLION) 40

TABLE 5 GLOBAL EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 49

TABLE 6 GLOBAL EPHARMACY MARKET, FOR APP, BY REGION, 2017–2027 (USD MILLION) 50

TABLE 7 GLOBAL EPHARMACY MARKET, FOR WEBSITE, BY REGION, 2017–2027 (USD MILLION) 51

TABLE 8 GLOBAL EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 9 GLOBAL EPHARMACY MARKET, FOR MARKETPLACE, BY REGION, 2017–2027 (USD MILLION) 50

TABLE 10 GLOBAL EPHARMACY MARKET, FOR PHARMACY, BY REGION, 2017–2027 (USD MILLION) 51

TABLE 11 GLOBAL EPHARMACY MARKET, FOR DIRECT, BY REGION, 2017–2027 (USD MILLION) 51

TABLE 12 GLOBAL EPHARMACY MARKET, BY REGION, 2017–2027 (USD MILLION) 59

TABLE 13 AMERICAS: EPHARMACY MARKET, BY REGION, 2017–2027 (USD MILLION) 60

TABLE 14 AMERICAS: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 61

TABLE 15 AMERICAS: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 61

TABLE 16 AMERICAS: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 17 NORTH AMERICA: EPHARMACY MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 63

TABLE 18 NORTH AMERICA: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 63

TABLE 19 NORTH AMERICA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 64

TABLE 20 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 21 US: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 65

TABLE 22 US: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 66

TABLE 23 US: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 24 CANADA: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 67

TABLE 25 CANADA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 68

TABLE 26 CANADA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 27 LATIN AMERICA: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 69

TABLE 28 LATIN AMERICA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 69

TABLE 29 LATIN AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 30 EUROPE: EPHARMACY MARKET, BY REGION, 2017–2027 (USD MILLION) 71

TABLE 31 EUROPE: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 72

TABLE 32 EUROPE: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 73

TABLE 33 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 34 WESTERN EUROPE: EPHARMACY MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 74

TABLE 35 WESTERN EUROPE: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 75

TABLE 36 WESTERN EUROPE: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 75

TABLE 37 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 38 GERMANY: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 76

TABLE 39 GERMANY: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 77

TABLE 40 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 41 FRANCE: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 78

TABLE 42 FRANCE: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 78

TABLE 43 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 44 UK: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 79

TABLE 45 UK: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 80

TABLE 46 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 47 ITALY: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 81

TABLE 48 ITALY: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 81

TABLE49 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 50 SPAIN: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 82

TABLE 51 SPAIN: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 83

TABLE 52 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 53 REST OF WESTERN EUROPE: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 84

TABLE 54 REST OF WESTERN EUROPE: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 85

TABLE 55 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 56 EASTERN EUROPE: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 86

TABLE 57 EASTERN EUROPE: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 86

TABLE 58 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 59 ASIA-PACIFIC: EPHARMACY MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 88

TABLE 60 ASIA-PACIFIC: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 89

TABLE 61 ASIA-PACIFIC: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 90

TABLE 62 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 63 CHINA: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 91

TABLE 64 CHINA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 91

TABLE 65 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 66 JAPAN: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 92

TABLE 67 JAPAN: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 93

TABLE 68 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 69 INDIA: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 94

TABLE 70 INDIA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 94

TABLE 71 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 72 AUSTRALIA: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 95

TABLE 73 AUSTRALIA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 96

TABLE 74 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 75 SOUTH KOREA: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 97

TABLE 76 SOUTH KOREA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 97

TABLE 77 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 78 REST OF ASIA-PACIFIC: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 98

TABLE 79 REST OF ASIA-PACIFIC: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 99

TABLE 80 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 81 MIDDLE EAST AND AFRICA: EPHARMACY MARKET, BY REGION, 2017–2027 (USD MILLION) 100

TABLE 82 MIDDLE EAST AND AFRICA: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 101

TABLE 83 MIDDLE EAST AND AFRICA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 101

TABLE 84 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 85 MIDDLE EAST: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 102

TABLE 86 MIDDLE EAST: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 103

TABLE 87 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 88 AFRICA: EPHARMACY MARKET, BY DRUG TYPE, 2017–2027 (USD MILLION) 104

TABLE 89 AFRICA: EPHARMACY MARKET, BY OPERATING PLATFORM, 2017–2027 (USD MILLION) 104

TABLE 90 NORTH AMERICA: EPHARMACY MARKET, BY BUSINESS MODEL, 2017–2027 (USD MILLION) 49

TABLE 91 MAJOR MANUFACTURERS IN THE GLOBAL EPHARMACY MARKET 106

TABLE 92 BENCHMARKING OF MAJOR COMPETITORS 107

TABLE 93 COMPETITOR DASHBOARD: GLOBAL EPHARMACY MARKET 108

TABLE 94 MOST ACTIVE PLAYER IN THE GLOBAL EPHARMACY MARKET 110

TABLE 95 ACQUISITION ACTIVITIES 111

TABLE 96 NEW PRODUCTS/SERVICE LAUNCHES 112

TABLE 97 COLLABORATIONS 113

TABLE 98 PARTNERSHIPS 113

TABLE 99 APPROVALS 113

TABLE 100 WALGREENS BOOTS ALLIANCE, INC.: PRODUCTS/SERVICES OFFERED 116

TABLE 101 WALGREENS BOOTS ALLIANCE, INC.: KEY DEVELOPMENTS 117

TABLE 102 WAL-MART, INC.: PRODUCTS/SERVICES OFFERED 120

TABLE 103 WAL-MART, INC.: KEY DEVELOPMENTS 120

TABLE 104 CVS HEALTH: PRODUCTS/SERVICES OFFERED 123

TABLE 105 CVS HEALTH: KEY DEVELOPMENTS 124

TABLE 106 DR. FOX PHARMACY: PRODUCTS/SERVICES OFFERED 127

TABLE 107 DR. FOX PHARMACY: KEY DEVELOPMENTS 127

TABLE 108 DOCMORRIS N.V.: PRODUCTS/SERVICES OFFERED 130

TABLE 109 DOCMORRIS N.V.: KEY DEVELOPMENTS 131

TABLE 110 ROWLANDS PHARMACY: PRODUCTS/SERVICES OFFERED 133

TABLE 111 OPTUMRX: PRODUCTS/SERVICES OFFERED 136

TABLE 112 OPTUMRX: KEY DEVELOPMENTS 136

TABLE 113 THE ONLINE DRUGSTORE: PRODUCTS/SERVICES OFFERED 139

TABLE 114 THE ONLINE DRUGSTORE LIFESCIENCES HOLDINGS CORPORATION: KEY DEVELOPMENTS 139

TABLE 115 WELL PHARMACY: PRODUCTS/SERVICES OFFERED 142

TABLE 116 WELL PHARMACY: KEY DEVELOPMENTS 142

TABLE 117 LLOYDSPHARMACY: PRODUCTS/SERVICES OFFERED 146

TABLE 118 LLOYDSPHARMACY: KEY DEVELOPMENTS 146

 

LIST OF FIGURES

FIGURE 1 GLOBAL EPHARMACY MARKET STRUCTURE 18

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 24

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL EPHARMACY MARKET 26

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL EPHARMACY MARKET 30

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL EPHARMACY MARKET 32

FIGURE 6 GLOBAL EPHARMACY MARKET SHARE, BY DRUG TYPE, 2019 (%) 37

FIGURE 7 GLOBAL EPHARMACY MARKET, BY DRUG TYPE, 2019 AND 2027 (USD MILLION) 38

FIGURE 8 GLOBAL EPHARMACY MARKET SHARE, BY OPERATING PLATFORM, 2019 (%) 48

FIGURE 9 GLOBAL EPHARMACY MARKET, BY OPERATING PLATFORM, 2019 AND 2027 (USD MILLION) 49

FIGURE 10 GLOBAL EPHARMACY MARKET SHARE, BY BUSINESS MODEL, 2019 (%) 48

FIGURE 11 GLOBAL EPHARMACY MARKET, BY BUSINESS MODEL, 2019 AND 2027 (USD MILLION) 49

FIGURE 12 GLOBAL EPHARMACY MARKET SHARE, BY REGION, 2019 (%) 58

FIGURE 13 GLOBAL EPHARMACY MARKET, BY REGION, 2019 AND 2027 (USD MILLION) 58

FIGURE 14 AMERICAS: EPHARMACY MARKET, BY REGION, 2019 AND 2027 (USD MILLION) 60

FIGURE 15 NORTH AMERICA: EPHARMACY MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION) 62

FIGURE 16 EUROPE: EPHARMACY MARKET, BY REGION, 2019 AND 2027 (USD MILLION) 71

FIGURE 17 WESTERN EUROPE: EPHARMACY MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION) 74

FIGURE 18 ASIA-PACIFIC: EPHARMACY MARKET, BY COUNTRY, 2019 AND 2027 (USD MILLION) 88

FIGURE 19 MIDDLE EAST AND AFRICA: EPHARMACY MARKET, BY REGION, 2019 AND 2027 (USD MILLION) 100

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL EPHARMACY MARKET 109

FIGURE 21 GLOBAL EPHARMACY MARKET, COMPETITIVE LANDSCAPE 110

FIGURE 22 WALGREENS BOOTS ALLIANCE, INC.: FINANCIAL OVERVIEW SNAPSHOT 115

FIGURE 23 WALGREENS BOOTS ALLIANCE, INC.: SWOT ANALYSIS 118

FIGURE 24 WAL-MART, INC.: FINANCIAL OVERVIEW SNAPSHOT 119

FIGURE 25 WAL-MART, INC.: SWOT ANALYSIS 121

FIGURE 26 CVS HEALTH: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 27 CVS HEALTH: SWOT ANALYSIS 125

FIGURE 28 DR. FOX PHARMACY: FINANCIAL OVERVIEW SNAPSHOT 126

FIGURE 29 DR. FOX PHARMACY: SWOT ANALYSIS 128

FIGURE 30 DOCMORRIS N.V.: FINANCIAL OVERVIEW SNAPSHOT 129

FIGURE 31 DOCMORRIS N.V.: SWOT ANALYSIS 131

FIGURE 32 ROWLANDS PHARMACY: FINANCIAL OVERVIEW SNAPSHOT 132

FIGURE 33 ROWLANDS PHARMACY: SWOT ANALYSIS 133

FIGURE 34 OPTUMRX: FINANCIAL OVERVIEW SNAPSHOT 135

FIGURE 35 OPTUMRX: SWOT ANALYSIS 137

FIGURE 36 THE ONLINE DRUGSTORE: FINANCIAL OVERVIEW SNAPSHOT 138

FIGURE 37 THE ONLINE DRUGSTORE LIFESCIENCES HOLDINGS CORPORATION: SWOT ANALYSIS 140

FIGURE 38 WELL PHARMACY: FINANCIAL OVERVIEW SNAPSHOT 141

FIGURE 39 WELL PHARMACY: SWOT ANALYSIS 143

FIGURE 40 LLOYDSPHARMACY: FINANCIAL OVERVIEW SNAPSHOT 145

FIGURE 41 LLOYDSPHARMACY: SWOT ANALYSIS 146

ePharmacy Market

ePharmacy Market was valued at USD 62,587.0 Million in 2019 and is expected to register a CAGR of 12.5% during the forecast period of 2020 to 2027

Segmentation

By Drug Type Foam Dressings Film Dressings Hydrocolloid Dressings Chg Adhesive Dressings Alginate Dressing Surgical Tapes Hydrogel Dressings Others
By Operating Platform Diabetic Foot Ulcers Pressure Ulcers Surgical And Traumatic Wounds Burns Ostomy Care Others
By Business Model Hospitals And Clinics Home Care Settings Others

Key Players

  • 3M
  • B. Braun Melsungen AG
  • Baxter International INC
  • Smith & Nephew Plc
  • Cardinal Health
  • Coloplast Corp.
  • ConvaTec Group Plc
  • Integra Lifesciences Holdings Corporation
  • MΓΆlnlycke Health Care AB
  • Avery Dennison Corporation

Drivers

  • Increasing online orders
  • The convenience provided in the delivery of medication discounted price
  • Rising investment for small companies
  • The rising number of counterfeit online pharmacies
Speak to Analyst Request a Free Sample

ePharmacy Market Overview


ePharmacy Market was valued at USD 62,587.0 Million in 2019 and is expected to register a CAGR of 12.5% during the forecast period of 2020 to 2027.


An E-Pharmacy is a pharmacy that operates over the internet and sends orders to customers through mail or shipping companies. The growth of the online pharmacies can be acknowledged from the following examples. The electronic prescription service (EPS) was aimed at rolling out in November 2019, according to the Department of Health, UK, claiming it would save the NHS through increasing efficiencies, reducing the amount of paper processing required, and reducing prescribing errors. In January 2019, Ping An Good Doctor, a one-stop healthcare ecosystem platform from China, announced that it had placed its One-minute Clinics across 8 provinces and cities in China and signed service contracts for nearly 1,000 units, providing healthcare services to more than 3 million users. Every One-minute Clinic has more than 100 categories of common drugs, all of which are cryogenically refrigerated to ensure their quality. New York in 2016 took the step of requiring prescribers to use electronic transmission of prescriptions to pharmacies.


Factors such as the convenience provided in the delivery of medication discounted price, and laws favoring the adoption of ePharmacy, are driving the growth of the ePharmacy market. Additionally, rising investment for small companies is also driving the growth of the ePharmacy market. However, the rising number of counterfeit online pharmacies is posing as a challenge for the growth of the ePharmacy market.


Market Dynamics


An online pharmacy, internet pharmacy, or mail-order pharmacy is a pharmacy that operates over the Internet and sends orders to customers through mail, shipping companies, or online pharmacy web portal. Key players operating in the ePharmacy market to provide cost-efficient and timely services to survive and succeed in an intensely competitive and growing market environment.


A shift in consumer preference toward the online purchase of medicines and rising penetration of high-speed internet is driving the growth of the ePharmacy market. An increase in the number of online pharmacies and the booming pharmaceutical industry further anticipates the ePharmacy market growth. As of January 2020, 50+ start-ups are operating in e-Pharmacy space in India, which provides quality and affordable medicines to about 5,000,000 patients per month across the country. The number of ePharmacy has grown with the rising investment in the sector. Stockholm-based online pharmacy Meds raised USD 5.7 million in a round led by Inbox Capital.


E-Pharmacy improves purchaser's comfort and access, this will above all advantage endless old-age patients living in family units, and patients who are not in a condition to go out to discover a drug store. Globally, the population aged 65 and over is growing faster than all other age groups. According to data from World Population Prospects: the 2019 Revision, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). The number of people aged 65 or more living in nursing homes is huge and suffering from chronic conditions such as diabetes, arthritis, eye diseases, or cognitive impairment. About 1.4 to 1.5 million people were living in nursing homes in the state according to research conducted by the Ohio State University Wexner Medical Center. The large number of geriatric populations suffering from chronic disease is expected to fuel ePharmacy market growth.


Global ePharmacy Market Share, by Drug Type, 2019 (%)
ePharmacy Market


Source: MRFR Analysis


Segmentation


Global ePharmacy Market has been divided based on Drug Type, Operating Platform, and Business Model.


The ePharmacy market, based on Drug Type, has been segregated into prescription drugs and over the counter (OTC) drugs. The prescription drugs segment accounted for the largest market share of 55.6% in 2019. This largest share can be attributed to its preference as compared to over the counter drugs.


The ePharmacy market, based on operating platform, has been segregated into app and website. The app segment accounted for the largest market share of 57.6% in 2019. The rising number of retail pharmacies launching apps for the delivery of products globally is the key factor owing to the growth of this segment.


On the basis of business model, the ePharmacy market is segregated into the marketplace, pharmacy, and direct. The marketplace segment accounted for the largest market share with a value of USD 33,222.2 million in 2019 due to the increasing number of customers buying medications and refilling it online.


Global ePharmacy Market Share, by Region, 2019 (%)
ePharmacy Market


Source: MRFR Analysis


Regional Analysis


Global ePharmacy market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are likely to dominate the global ePharmacy market owing to the presence of major manufacturers, raising awareness, and rising product launches by major players in the region. In 2019, the Americas accounted for the largest market share of 48.9% in the global ePharmacy market. This large share is majorly attributed to the presence of major ePharmacy players, and reliance of the general population on the online delivery of consumable goods. According to the most recent Statistics Canada report, retail e-commerce sales reached USD 2.3 billion in November, accounting for 4.2% of total retail trade. On a year-over-year basis, retail e-commerce increased by 20.1%, while total unadjusted retail sales rose 1.1%.


Europe held a substantial share in the global ePharmacy market. The ePharmacy market in Europe is expected to propel during the forecast period, owing to factors such as increasing online orders, the rapid increase in e-commerce, rising prevalence of chronic diseases, an increase in the geriatric population, and well-developed IT infrastructures. For instance, according to NCBI in Europe, the amount of online pharmacies is continuously increasing, while the amount of physical pharmacies is slightly decreasing (21,602 pharmacies in the year 2008) with only 20,441 operating public pharmacies in 2015. Glovo is a Spanish start-up founded in Barcelona in 2015. It is an on-demand courier service that purchases, picks up, and delivers products ordered through its mobile app. In Spain, the company observed a 60% growth in pharmaceutical orders during the pandemic of coronavirus. As of April 2020, it has provided around 133,000 masks, 71,000 pairs of gloves, and 2,500 liters of hand sanitizer gel worldwide through couriers.


The fast growth of the Asia-Pacific region is due to rising diabetes cases and the increasing per capita income along with government initiatives to enhance the quality of healthcare. China, India, and Australia have a lucrative market for ePharmacy due to the growing older population. Moreover, according to the report published by the United Nations in 2015, the number of older people aged 60 years or above in the world is predicted to grow by 56% between 2015 and 2030. Nearly 66% of the older population out of the total global population would also reside in the Asia-Pacific region. The increasing geriatric population will lead to an increase in metabolic disorders, which will, in turn, increase the patient population in need of delivery of medications and lead to growth in the ePharmacy market.


The ePharmacy market growth in the Middle East & Africa can be attributed to the novel public-private partnerships (PPP) business model, developing healthcare infrastructure, and government support. South Africa's Gauteng department of health in partnership with Right to Care and Right ePharmacy launched a groundbreaking "ATM pharmacy" also known as pharmacy dispensing unit (PDU). Right ePharmacy is an innovative, strategic solution provider for the dispensing, distribution, and collection of medicine. Right ePharmacy is the center of excellence for its parent company, Right to Care, spearheading disruptive innovation, and enhancing differentiated models of pharmaceutical care in Africa. So far 16 pharmacy dispensing units have been installed near shopping malls in Alexandra, Soweto, and Diepsloot townships in Johannesburg, and have served thousands of patients between March and the end of May. During 2018, medication was picked up 19,352 times from PDUs.


Key Players


The Prominent Players in the Global ePharmacy Market are 3M, B. Braun Melsungen AG, Baxter International INC, Smith & Nephew Plc, Cardinal Health, Coloplast Corp., ConvaTec Group Plc, Integra Lifesciences Holdings Corporation, Mölnlycke Health Care AB and Avery Dennison Corporation.


Market Segmentation


ePharmacy Market, by Drug type



  • Foam Dressings

  • Film Dressings

  • Hydrocolloid Dressings

  • CHG Adhesive Dressings

  • Alginate Dressing

  • Surgical Tapes

  • Hydrogel Dressings

  • Collagen Dressings

  • Barrier Tapes

  • Tissue Sealants

  • Negative Pressure Wound Therapy Drapes

  • Others


ePharmacy Market, by operating platform



  • Diabetic Foot Ulcers

  • Pressure Ulcers

  • Surgical and Traumatic Wounds

  • Burns

  • Ostomy Care

  • Others


ePharmacy Market, by Business model



  • Hospitals and Clinics

  • Home Care Settings

  • Others


ePharmacy Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East and Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Additional 5 Company Profiles


Intended Audience



  • Hospitals and Clinics

  • Pharmaceutical & Biotechnology Companies



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2019: USD 62,587.0 Million
  • 2027: Significant Value
  •   CAGR   12.5% (2020-2027)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Drug Type, Operating platform, Business model and Region
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   3M, B. Braun Melsungen AG, Baxter International INC, Smith & Nephew Plc, Cardinal Health, Coloplast Corp., ConvaTec Group Plc, Integra Lifesciences Holdings Corporation, MΓΆlnlycke Health Care AB and Avery Dennison Corporation
      Key Market Opportunities

  • Low penetration of advanced technology
  • The rapid increase in e-commerce
  • Rising prevalence of chronic diseases
  • An increase in the geriatric population and well-developed IT infrastructures.
  •   Key Market Drivers

  • Increasing online orders
  • The convenience provided in the delivery of medication discounted price
  • Laws favoring the adoption of ePharmacy
  • Rising investment for small companies
  • The rising number of counterfeit online pharmacies


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    North America and Europe are predicted to have the largest share in the ePharmacy market.

    Different product type segments available in the ePharmacy include weight loss, cold and flu, vitamins, skin care, dental, and others.

    Rising popularity of e-commerce platforms and increasing prevalence of chronic diseases are adding market growth.

    Low penetration of advanced technology especially in underdeveloped regions may limit the ePharmacy market growth.

    Key competitors in the ePharmacy market include Walmart Stores, Inc, Express Scripts Holding Company, Medisave, Giant Eagle, Inc., CVS Health, PlanetRx, DocMorris, Optum Rx, Inc., The Kroger Co., eDrugstore.com, Walgreen Co., Sanicare AB, drugstore.com Inc., Canada Drugs, Lloyds Pharmacy Ltd., Rowlands Pharmacy, and Secure Medical, Inc.